Research output per year
Research output per year
Search results
-
2023
Health care and socioeconomic costs for long-term survivors after implementation of checkpoint-inhibitors and targeted agents for metastatic melanoma
Soerensen, A. V., Kjellberg, J., Ibsen, R., Bastholt, L., Schmidt, H. & Svane, I. M., Oct 2023, In: European journal of cancer (Oxford, England : 1990). 192, p. 113288 113288.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
2022
Active use of electronic patient-reported outcome in kidney cancer and effect on self-reported physical function: PRORECECA study protocol
Rasmussen, I. M. L., Moeller, A. K. H., Soerensen, A. V., Persson, G., Taarnhoej, G. A., Palshof, J. A. & Pappot, H., Dec 2022, In: Acta Oncologica. 61, 12, p. 1473-1476 4 p.Research output: Contribution to journal › Letter › peer-review
-
Individualizing the Oncological Treatment of Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study
Rasmussen, I. M. L., Soerensen, A. V., Møller, A. K., Persson, G. F., Palshof, J. A., Taarnhøj, G. A. & Pappot, H., 15 Sept 2022, In: JMIR research protocols. 11, 9, p. e36632 e36632.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
2020
Improved Progression-Free Long-Term Survival of a Nation-Wide Patient Population with Metastatic Melanoma
Soerensen, A. V., Ellebaek, E., Bastholt, L., Schmidt, H., Donia, M. & Svane, I. M., 11 Sept 2020, In: Cancers. 12, 9Research output: Contribution to journal › Journal article › Research › peer-review
-
2016
A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Soerensen, A. V., Geertsen, P. F., Christensen, I. J., Hermann, G. G., Jensen, N. V., Fode, K., Petersen, A., Sandin, R. & Donskov, F., 2016, In: Acta oncologica . 55, 3, p. 341-48Research output: Contribution to journal › Journal article › Research › peer-review
12 Citations (Scopus) -
2015
Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
Soerensen, A. V., Donskov, F., Kjellberg, J., Ibsen, R., Hermann, G. G., Jensen, N. V., Fode, K. & Geertsen, P. F., 18 Dec 2015, In: European Urology. 68, 6, p. 516-22Research output: Contribution to journal › Journal article › Research › peer-review
13 Citations (Scopus) -
2014
Analysis of the implementation of tyrosine kinase and mTOR-inhibitor treatment of metastatic renal cell carcinoma in Denmark
Sørensen, A. V., 2014, University of Copenhagen.Research output: Book/Report › Ph.D. thesis
-
Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2
Sørensen, A. V., Hermann, G. G., Jensen, N., Petersen, A., Spliid, N. H., Sandin, R., Fode, K. & Geertsen, P. F., Feb 2014, In: European journal of cancer (Oxford, England : 1990). 50, 3, p. 553-62 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
64 Citations (Scopus)